Comments

Transcript

About this Series

In an era of lipid management, cardiologists continue to encounter a steady stream of patients who have an elevated risk for an atherosclerotic cardiovascular event because of stubborn hyperlipidemia. Barriers to effective reduction of low-density lipoprotein levels persist.

Filmed on location at the historic Michael E. DeBakey Library and Museum, cardiologists and cardiometabolic researchers from Houston's Baylor College of Medicine weigh in on factors that undermine clinician and patient efforts to reduce LDL levels and diminish cardiovascular risk.

In discussions ranging from recognition and treatment of hypercholesterolemia, to common misconceptions about statin safety, to the emerging benefits of PCSK9 inhibitors, Baylor experts tackle the key issues in lipid management.

Show More

Who's Who
{{#each bp-whos-who.people}}
doc
●●●
{{{title}}}
{{{name}}} {{{addComma prof}}}
{{{desc}}}
{{#if disclosureTitle }} Disclosure
Disclosure
{{{disclosureTitle}}}
{{{disclosureText}}}
{{/if}}
More on Dyslipidemia